Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
Late Phase CRO Phase IV Medpace
Late Phase Clinical Research
request info
First Name*:
Last Name*:
Company*:
Email*:
Leave a Message:


Please enter the security code


Find out how our medical, regulatory, and operational expertise in late phase post-marketing clinical development can help with your next study or program.


GENERAL CAPABILITIES

VIEW NOW more

Late Phase Fact Sheet: Post-marketing Capabilities

Late Phase White Paper: White Paper: Early Planning for Late Phase Success

Risk Based Monitoring Webinar: Sponsors, CROs and RBM: Getting Aligned for Success

Risk Based Monitoring White Paper:The Role of the CRO in Effective Risk-Based Monitoring

You’ve beaten the odds by bringing your product to a successful regulatory approval. Now get ready for the real world- making your product a commercial success. You now have new challenges to face including safety and efficacy data considerations, outcome decisions, risk management issues and post-marketing commitments.

Medpace, long known for its therapeutic and regulatory advantage, has the knowledge to help you find your way. Medpace has the necessary expertise and ability to conduct Phase IIIb-IV studies in both pharmaceutical and medical device areas. Our therapeutic and regulatory experts have global operational reach, allowing us to offer full service capabilities that ensure a successful commercial launch of your product.

Medpace is a best-in-class strategic partner for late phase drug and device development programs. Staffed with the industry’s most therapeutically focused leaders, Medpace’s late phase clinical operations teams have expertise in development and trial design best practices, dedicated submissions team to accelerate startup, and noted relationships with key investigative sites, to assure the highest level of quality for outcomes research.

Medpace Late Phase can conduct both interventional and non-interventional type studies:

  • Phase IIIb and IV randomized clinical trials
  • Observational epidemiologic studies
  • Expanded access programs
  • Post-authorization safety studies
  • Health Economics and Outcomes Research
  • Competitive marketing claims studies
  • Registries

Learn more about late phase development. Access slides from Dr. Alex Artyomenko's presentation at Outsourcing in Clinical Trials, Europe.